Pancreatitis in adult with acute lymphoblastic leukemiausing L-asparaginase and simvastatin: case report and systematic review

Rodrigues, Renne; Gavarrete, Diogo D; Bernardi, Érika A. T; Munhoz, Eduardo C.
Medicina (Ribeiräo Preto) ; 49(1): 90-94, jan.-fev. 2016.
Artículo en Inglés | LILACS | ID: lil-790214

Documentos relacionados

  1. Response surface methodology based optimized production, purification, and characterization of L-asparaginase from Fusarium foetens.
  2. Comparative Effectiveness of Peg-Asparaginase and L-Asparaginase on Coagulation Markers Among Pediatric Patients with Acute Lymphoblastic Leukemia.
  3. PEG-asparaginase treatment regimens for acute lymphoblastic leukaemia in children: a network meta-analysis.
  4. Acute pancreatitis in children with acute lymphoblastic leukemia correlates with L-asparaginase dose intensity.
  5. Diagnosis, prognostic factors, and assessment of ALL in adults: 2024 ELN recommendations from a European expert panel.
  6. Individualized dosing guidelines for PEGasparaginase and factors influencing the clearance: a population pharmacokinetic model.
  7. Can Machine Learning Models Predict Asparaginase-associated Pancreatitis in Childhood Acute Lymphoblastic Leukemia.
  8. [Recurrent thrombosed external hemorrhoids due to L-asparaginase administration in a Philadelphia chromosome-positive acute lymphoblastic leukemia patient].
  9. Elucidation of the Active Form and Reaction Mechanism in Human Asparaginase Type III Using Multiscale Simulations.
  10. Clinical Characteristics and Short-Term Outcomes of Children With Asparaginase-Associated Pancreatitis.